Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
NGNE compared with STOK: revenue, margins and what each company keeps, and the suppliers and customers both name
NGNE
Neurogene Inc.
Change
Mkt cap
Revenue
Revenue
STOK
Stoke Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
NGNE
Neurogene Inc.
vs
STOK
Stoke Therapeutics, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Price
Desk
News
Calendar
Saved
Search
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
NGNE, solid
STOK, dashed
NGNE
Neurogene Inc.
Change
26.72
· pre 26.72
· delayed
Mkt cap
$600.1M
Revenue
$925,000
Q2 FY24
Revenue
—
STOK
Stoke Therapeutics, Inc.
Change
26.46
· pre 26.46
· delayed
Pre-market
Nov 2 '26
delayed
Mkt cap
$1.7B
Revenue
$9M
Q2 FY26
Revenue
$184M
FY25
vs
Compare
Pre-market
Nov 2 '26
delayed
NGNE
Neurogene Inc.
vs
STOK
Stoke Therapeutics, Inc.
26.72
pre 26.72
delayed
Price
26.46
pre 26.46
delayed
$600.1M
Mkt cap
$1.7B
Q2 FY24
$925,000
Revenue
$9M
Q2 FY26
—
Revenue
$184M
FY25
Change
Change
NGNE
26.72
vs
STOK
26.46
Pre-market
Nov 2 '26
delayed